Sarah L. Martindale

Sarah L. Martindale

Auto-generated profile, based on publicly available information

Sarah L. Martindale

Department of Translational Neuroscience, Wake Forest School of Medicine, Winston-Salem, NC, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2017 in Neuropsychology Review
Verified
Journal Article
Closed access
PDF file
TBTimothy W. Brearly
Timothy W. Brearly
RSRobert D. Shura
Robert D. Shura
SMSarah L. Martindale
Sarah L. Martindale
RLRory A. Lazowski
Rory A. Lazowski
DLDavid D. Luxton
David D. Luxton
JRJared A. Rowland
Jared A. Rowland

18 February 2012 in Neuropsychology Review
Verified
Journal Article
Closed access
PDF file
SDSara Dolan
Sara Dolan
SMSarah Martindale
Sarah Martindale
JRJennifer Robinson
Jennifer Robinson
NKNathan A. Kimbrel
Nathan A. Kimbrel
EMEric C. Meyer
Eric C. Meyer
Suzy Bird GulliverSuzy Bird Gulliver
Suzy Bird Gulliver

16 May 2018 in Neuropsychology Review
Verified
Journal Article
Closed access
PDF file
RSRobert D. Shura
Robert D. Shura
TBTimothy W. Brearly
Timothy W. Brearly
JRJared A. Rowland
Jared A. Rowland
SMSarah L. Martindale
Sarah L. Martindale
HMHolly M. Miskey
Holly M. Miskey
KDKevin Duff
Kevin Duff

8 April 2021 in Neuropsychology
Verified
Journal Article
Closed access
AOAnna S. Ord
Anna S. Ord
RSRobert D. Shura
Robert D. Shura
ASAshley R. Sansone
Ashley R. Sansone
SMSarah L. Martindale
Sarah L. Martindale
KTKatherine H. Taber
Katherine H. Taber
JRJared Rowland
Jared Rowland
To evaluate the relationships among performance validity, symptom validity, symptom self-report, and objective cognitive testing. Combat Veterans (N = 338) completed a neurocognitive assessment battery and several self-report symptom measures assessing depression, PTSD symptoms, sleep quality, pain interference, and neurobehavioral complaints. All participants also completed two performance validity tests (PVTs) and one stand-alone symptom validity test (SVT) along with two embedded SVTs. Results of an exploratory factor analysis revealed a three-factor solution: Performance Validity, Cognitive Performance, and Symptom Report (SVTs loaded on the third factor). Results of t-tests demonstrated that participants who failed PVTs displayed significantly more severe symptoms and significantly worse performance on most measures of neurocognitive functioning as compared to those who passed. Participants who failed a stand-alone SVT also reported significantly more severe symptomatology on all symptom report measures, but the pattern of cognitive performance differed based on the selected SVT cutoff. Multiple linear regressions revealed that both SVT and PVT failure explained unique variance in symptom report, but only PVT failure significantly predicted cognitive performance. Performance and symptom validity tests measure distinct but related constructs. SVTs and PVTs are significantly related to both cognitive performance and symptom report; however, the relationship between symptom validity and symptom report is strongest. SVTs are also differentially related to cognitive performance and symptom report based on the utilized cutoff score.

3 July 2019 in The Clinical Neuropsychologist
Verified
Journal Article
Closed access
RSRobert D. Shura
Robert D. Shura
SMSarah L. Martindale
Sarah L. Martindale
KTKatherine H. Taber
Katherine H. Taber
AHAlana M. Higgins
Alana M. Higgins
JRJared A. Rowland
Jared A. Rowland
Objective: Embedded validity measures are useful in neuropsychological evaluations but should be updated with new test versions and validated across various samples. This study evaluated Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Digit Span validity indicators in post-deployment veterans. Method: Neurologically-intact veterans completed structured diagnostic interviews, the WAIS-IV, the Medical Symptom Validity Test (MSVT), and the b Test as part of a larger study. The Noncredible group included individuals who failed either the MSVT or the b Test. Of the total sample (N = 275), 21.09% failed the MSVT and/or b Test. Diagnostic accuracy was calculated predicting group status across cutoff scores on two Digit Span variables, four Reliable Digit Span (RDS) variables, and two Vocabulary minus Digit Span variables. Results: Digit Span age-corrected scaled score (ACSS) had the highest AUC (.648) of all measures assessed; however, sensitivity at the best cutoff of <7 was only 0.17. Of RDS measures, the Working Memory RDS resulted in the highest AUC (.629), but Enhanced RDS and Alternate RDS produced the highest sensitivities (0.22). Overall, cutoff scores were consistent with other studies, but sensitivities were lower. Vocabulary minus Digit Span measures were not significant. Conclusions: Digit Span ACSS was the strongest predictor of noncredible performance, and outperformed traditional RDS variants. Sensitivity across all validity indicators was low in this research sample, though cutoff scores were congruent with previous research. Although embedded Digit Span validity indicators may be useful, they are not sufficient to replace standalone performance validity tests.

1 November 2021 in Journal of Psychiatric Research
Verified
Journal Article
Open access
SMSarah L. Martindale
Sarah L. Martindale
AOAnna S. Ord
Anna S. Ord
LRLakeysha G. Rule
Lakeysha G. Rule
JRJared Rowland
Jared Rowland
Blast exposure is common among service members, but the chronic psychiatric effects associated with blast exposure are not well-characterized independent of a resulting mild traumatic brain injury (TBI). This analysis evaluated whether blast exposure severity was independently associated with or exacerbated symptom report beyond posttraumatic stress disorder (PTSD) and mild TBI. Participants were Iraq and Afghanistan combat veterans (N = 275; 86.55% male), 71.27% with history of blast exposure, 29.82% current diagnosis of PTSD, and 45.45% with mild TBI. All participants completed diagnostic interviews for PTSD, lifetime TBI, and lifetime blast exposure. Self-reported psychiatric and health outcomes included posttraumatic stress symptoms, depressive symptoms, neurobehavioral symptoms, sleep quality, pain interference, and quality of life. Blast severity was associated with PTSD (B = 2.00), depressive (B = 0.76), and neurobehavioral (B = 1.69) symptoms beyond PTSD diagnosis and mild TBI history. Further, blast severity accounted entirely (i.e., indirect/mediation effect) for the association between TBI and posttraumatic stress (B = 1.62), depressive (B = 0.61), and neurobehavioral (B = 1.38) symptoms. No interaction effects were present. Exposure to blast is an independent factor influencing psychiatric symptoms in veterans beyond PTSD and mild TBI. Results highlight that blast exposure severity may be a more relevant risk factor than deployment mild TBI in combat veterans and should be considered in the etiology of psychiatric symptom presentation and complaints. Further, severity of psychological distress due to the combat environment may be an explanatory mechanism by which blast exposure mediates the relationship between mild TBI and symptom outcomes.